Taro Pharmaceutical Industries Ltd (TARO)
NYSE NYSE Primary Summary
TARO Chart
FINAL REMINDER TARO DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Taro Pharmaceutical Industries Ltd. Investors to Participate in the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / November 12, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
FINAL TARO DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Taro Pharmaceutical Industries Ltd. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / November 11, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
TARO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Taro Pharmaceutical Industries Ltd. to Contact the Firm Today!
NEW YORK, NY / ACCESSWIRE / November 10, 2024 / Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Taro Pharmaceutical Industries Ltd. ("Taro" or "the Company") (NYSE:TARO) and certain of its officers.
Taro Pharmaceutical Industries Ltd Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| AH Andrew Heistad Mason Street Advisors LLC | 51,000 | $1.45M | $1.45M | - | - |
Taro Pharmaceutical Industries Ltd (TARO) FAQ
What does "Delisted" mean?
What was the last recorded dividend?
How long did the company pay dividends?
Were there any stock splits?
What was the last known trading price?
Taro Pharmaceutical Industries Ltd Profile
| - Industry | - Sector | Mr. Uday V. Baldota CEO | NYSE Exchange | M8737E108 CUSIP |
| US Country | 1,554 Employees | 28 Dec 2018 Last Dividend | 27 Jul 2001 Last Split | 1 Apr 1993 IPO Date |
Overview
Taro Pharmaceutical Industries Ltd. is a science-driven pharmaceutical entity engaged in the development, production, and international marketing of prescription and over-the-counter (OTC) medication. Founded in 1959 and headquartered in Haifa, Israel, the company has expanded its operations across the United States, Canada, Israel, and other global markets. As an integral part of its strategic growth, Taro Pharmaceutical is dedicated to offering innovative pharmaceutical solutions across various therapeutic categories. Its commitment to quality and research has positioned it as a leader in the pharmaceutical industry. Additionally, it operates as a subsidiary of Sun Pharmaceutical Industries Limited, one of the largest pharmaceutical companies worldwide, after being associated with Alkaloida Chemical Company Zrt. This strategic alliance enhances Taro's capabilities in innovations and market reach, further solidifying its presence in the global pharmaceutical landscape.
Products and Services
Taro Pharmaceutical Industries Ltd. boasts a diverse portfolio of products designed to meet a wide array of healthcare needs. Its offerings encompass an extensive range of therapeutic categories and formulations, ensuring accessibility and efficacy:
- Allergy: Products designed to alleviate allergic symptoms, providing relief through various forms of medication.
- Analgesic, Antibacterial, Antibiotic, Anticonvulsant: A series of treatments targeting pain relief, bacterial infections, and conditions requiring antibiotics or seizure management.
- Antiemetic, Antifungal, Anti-inflammatory: Solutions for nausea, fungal infections, and inflammation, aiding in the comfort and recovery of patients.
- Anti-cancer, Antiplatelet Agent: Specialized medications aimed at cancer treatment and prevention of blood clots.
- Cardiovascular, CNS, Corticosteroid: Therapies focused on heart health, central nervous system support, and steroid use for conditions such as inflammation.
- Dermatology: A wide range of products catering to skin health, including treatments for various skin conditions.
- Endocrine, Gastrointestinal: Medications for hormonal disorders and digestive system ailments.
- Laxative, Narcotics, Neuropathic Pain: Treatments addressing constipation, controlled pain relief substances, and nerve pain management.
- Neuropsychiatric, Sedative/Hypnotic: Medicines for psychiatric conditions and those aiding in sleep or sedation.
- Formulations: Taro's products are available in multiple formulations, including capsules, creams, injectables, and tablets, among others, catering to a wide range of administration preferences and medical necessities.
Through direct sales and partnerships with wholesalers, retail chains, hospitals, and e-commerce platforms, Taro ensures its products are accessible to a broad audience, including healthcare institutions and private pharmacies. This strategic distribution model enhances the availability of Taro’s pharmaceutical solutions to patients and healthcare professionals worldwide.
